STRATA Skin Sciences (SSKN) Shareholder's Equity Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -48.93% |
| Sep 30, 2025 | -60.79% |
| Jun 30, 2025 | -71.23% |
| Mar 31, 2025 | -49.96% |
| Dec 31, 2024 | -41.95% |
| Sep 30, 2024 | -28.92% |
| Jun 30, 2024 | -28.31% |
| Mar 31, 2024 | -26.88% |
| Dec 31, 2023 | -21.16% |
| Sep 30, 2023 | -14.52% |
| Jun 30, 2023 | -14.21% |
| Mar 31, 2023 | -11.68% |
| Dec 31, 2022 | -8.67% |
| Sep 30, 2022 | -8.92% |
| Jun 30, 2022 | -8.81% |
| Mar 31, 2022 | -7.70% |
| Dec 31, 2021 | -6.66% |
| Sep 30, 2021 | -5.09% |
| Jun 30, 2021 | -5.81% |
| Mar 31, 2021 | 10.99% |
| Dec 31, 2020 | 9.21% |
| Sep 30, 2020 | 7.70% |
| Jun 30, 2020 | 24.56% |
| Mar 31, 2020 | 35.92% |
| Dec 31, 2019 | 23.98% |
| Sep 30, 2019 | 22.04% |
| Jun 30, 2019 | 19.48% |
| Mar 31, 2019 | 26.23% |
| Dec 31, 2018 | 24.77% |
| Sep 30, 2018 | 24.49% |
| Jun 30, 2018 | 4.24% |
| Dec 31, 2017 | 17.43% |
| Sep 30, 2017 | 10.88% |
| Jun 30, 2017 | 24.72% |
| Mar 31, 2017 | 20.68% |
| Dec 31, 2016 | 21.93% |
| Sep 30, 2016 | 15.56% |
| Jun 30, 2016 | -0.50% |
| Mar 31, 2016 | -13.75% |
| Dec 31, 2015 | 4.80% |
| Sep 30, 2015 | -3.33% |
| Jun 30, 2015 | 12.14% |
| Dec 31, 2014 | -25.60% |
| Sep 30, 2014 | -6.87% |
| Jun 30, 2014 | -32.07% |
| Dec 31, 2013 | -36.10% |